Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid-eluting implant for chronic rhinosinusitis
NCT05450471Phase 3Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Aug 2021
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of Corticosteroid lotion in chronic rhinosinusitis (CRS) (2 arms), sponsored by Universidade de São Paulo. Primary endpoints: Nasal Obstruction Symptom Evaluation (NOSE) at Day 90, Nasal Endoscopic Evaluation at Day 90 and 1 more. Status: unknown.
02
Drugs
Corticosteroid lotion
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT05450471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05450471.